health care & pharmaceutical business: key challenges & it value
TRANSCRIPT
Health Care & Pharmaceutical BusinessKey Challenges & IT value
Mauricio Campos SuarezNovember 2016
Content• Key Challenges• The transformation• IT role
Health Care & Pharmaceutical BusinessKey Challenges & IT value
Pharma Key challengesExternal factors
• Global exponential population growth• Increase in life expectancy• Increase of chronic diseases
Global exponential population
growth
https://www.census.gov/popclock/ UNITED 7Billion Actions
Global increase in
life expectancy
Increase ofchronic diseases
http://www.who.int/kobe_centre/ageing/en/
Estimated Healthcare uti-lization by 2030
< 65 years> 65 years
Polulation > 650%
50%
100%
150%
200%
2030Now
Chronic disease0%
20%40%60%80%
100%120%140%
2030Now
Growth
Conservative, Diabetes prevalence will increase 165% between now and 2050
Source http://www.census.gov/
+ 500 million people
+ 46 million people (only US)
Pharma Key challengesInternal factors
• Patents expiration• Inefficiencies• Pipeline shrink• Internal Complexity/High Cost
New Molec1ule chances: 0,01 % success in 15
years
10 years exclusive commercialization
Key challengesInternal factors: R&D
Top Pharma R&D budget around u$s
150 bln
New medicines registration
New playersBig pharma
Equal to around 50 countries
GDP together
Key challengesInternal factors: R&D
http://unstats.un.org/unsd/snaama/dnllist.asp https://www.ft.com
The Transformation
Reinventing Pharma Business
Drive EfficienciesAlliances Management
Perform
InnovateBusiness Development
Transform
Leverage IT to accelerate the transformation
• Information as a key asset
• Outcome based HealthCare, Predictive Analytics
• “Broadening horizons”• Non-traditional Pharma Players &
Startups partnership
• “It’s all about our patients”
• e-Patient
• “You will not always see the doctor”• Telemedicine & Technologic solution
to reduce HC costs
Business model
development
Add value & build trust
Insights management
Technology Ecosystem
Collaboration
Pharma Transformation: IT Value
Beyond the pill
Shortage of up to 200,000 doctors by 2020 in US only
By 2020 the estimation is to move 40% of health care to the home
Global telemedicine market expected to reach close to USD 48.10 billion in revenue by 2019
E-Patient
ePatients are the individuals who are equipped, enabled, empowered and engaged in their health and health care (HC) decisions. Envisioning HC as an equal partnership between e-patients and HC professionals and systems that support them
e-Patients.net
Digitally enabled solutions are becoming critical to serving both parties’ (Payors, Patients) needs
Influenza epidemicsprediction
• Google prediction (in black) • Actual flu cases (in red) Source Nature.com
+ 90 million people (US) search in Internet their health problems
Big data revolution in healthcare
EXAMPLE
Estimation based on internet searching data
Big data revolution in healthcare
Payors and governments have an ever sharper focus on managing costs while delivering improved patient outcomes, putting an even greater onus on pharma companies to demonstrate the value of their drugs in the real world—not just in randomized controlled trials—if they are to retain market access and premium pricing
New players
EXAMPLEThe big majority of technological companies have a HealthCare division
Open Challenges to Start-ups
EXAMPLES
More about this at….http://www.globalchange.comhttp://www.gapminder.orghttp://www.silverbook.orghttp://www.census.govhttp://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/the-road-to-digital-success-in-pharmahttps://hbr.org/2013/09/value-based-health-care-is-inevitable-and-thats-good